Abstract
The developmentally-dependent differences in the biological significances and effects of PUFA-OMEGA-6 (namely of arachidonic acid) and PUFA-OMEGA-3 (namely of docosahexaenoic acid) are discussed. The clinical results as well as developmental experiences are indicating a hypothesis of the evolution that created mutual relationship between those two substances (with immunological basis and following recuperation). The anti-inflammatory actions of PUFA-OMEGA-3 are the most visible (and significant) contrasts as compared with the large affects of namely arachidonic acid and its metabolites.
| Originalsprog | Engelsk |
|---|---|
| Tidsskrift | Prague medical report |
| Vol/bind | 112 |
| Udgave nummer | 2 |
| Sider (fra-til) | 81-92 |
| Antal sider | 12 |
| ISSN | 1214-6994 |
| Status | Udgivet - 2011 |